University of York NHS Centre for Reviews and Dissemination.Effectiveness Matters—Screening for Prostate Cancer.1997; 2(2).
2.
AdolfssonJ, SteineckG, WhitmoreW.M.Jr.Recent results of management of palpable clinically localised prostate cancer.Cancer1993; 72: 310–22.
3.
KramerBS, BrownMJ, OrirokPC, PotoskyAL, GohagenJK. Prostate cancer screening: what we know and what we need to know.Ann Intern Med1993; 229: 914.
4.
WiltTJ, BrawerMK. The prostate cancer intervention versus observation trial: a randomised trial comparing radical prostatectomy versus expectant therapy for the treatment of clinically localised prostate cancer.J Urol1994; 152: 1910.
5.
American Cancer Society. Cancer Facts and Figures 1985.ACS, 1985.
6.
ParkerSL, TongT, BoldenS, WingoPA. Cancer statistics.CA Cancer J Clin1996; 65: 5–27.
7.
BreslowN, ChanCW, DhomGLatent carcinoma of prostate at autopsy in seven areas.Int J Cancer1977; 20: 680–8.
8.
KramerBS, GohaganJK, ProrokPC. Is screening for prostate cancer the current gold standard—“no”.Europ J Cancer1997; 33: 348–53.
9.
CarlinBI, ResnickMI. Anatomic approach to radical perineal prostatectomy.Urol Clin N Am1995; 22: 461–73.